* Program subject to change
Level: Experienced
Rachele Hendricks-Sturrup, DHSc, MSc, MA
Duke-Margolis Center for Health Policy, Washington, DC, USA
Andre Araujo, PhD
GSK, Kennett Square, PA, USA
Jaclyn L. Bosco, PhD, MPH
IQVIA, Cambridge, MA, USA
Sebastian Schneeweiss, MD, ScD
Harvard Medical School; Brigham and Women’s Hospital, Boston, MA, USA
Marc Berger, MD
Marc L. Berger, LLC, New York, NY, USA
John Concato, MD, MS, MPH
Food and Drug Administration, Silver Spring, MD, USA
Gracy Crane, PhD
Roche Products Limited, Welwyn, HRT, United Kingdom
Laurie Lambert, PhD
Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada
Daniel Leaver Morales
EMA, Amsterdam, Netherlands
Richard Willke, PhD
ISPOR, Lawrenceville, NJ, USA
Adam Aten, MPH, MSc
Duke-Margolis Center for Health Policy, Bethesda, MD, USA
C. Daniel Mullins, PhD
University of Maryland School of Pharmacy, Baltimore, MD, USA
Shirley Wang, PhD, MSc
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Nancy Dreyer, MPH, PhD, FISPE
IQVIA Real World Solutions, Newton, MA, USA
Stephen Duffield, PhD, MD
NICE, Liverpool, United Kingdom
Wim Goettsch, PhD
National Health Care Institute (ZIN); Utrecht University, Division of Pharmacoepidemiology and Clinical Pharmacology, Diemen, Netherlands
Ashley Jaksa, MPH
Aetion, Inc, Boston, MA, USA
Tae Hyun Jung, PhD
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now
×